Literature DB >> 18680144

FIAT represses bone matrix mineralization by interacting with ATF4 through its second leucine zipper.

Vionnie W C Yu1, Claude Gauthier, René St-Arnaud.   

Abstract

We have characterized FIAT, a 66 kDa leucine zipper (LZ) protein that dimerizes with activating transcription factor 4 (ATF4) to form inactive dimers that cannot bind DNA. Computer analysis identifies three putative LZ motifs within the FIAT amino acid sequence. We have used deletion- and/or site-specific mutagenesis to individually inactivate these motifs in order to identify the functional LZ that mediates the FIAT-ATF4 interaction. Amino acids 194-222 that encode the FIAT LZ2 were deleted (mutant FIAT ZIP2 DEL). We inactivated each zipper individually by replacing two or three leucine residues within each zipper by alanine residues. The engineered mutations were L142A/L149A (mutant M1, first zipper), L208A/L215A/L222A (mutant M2, second zipper), and L441A/L448A (mutant M3, third zipper). MC3T3-E1 osteoblastic cells with an integrated 1.3 kb mouse osteocalcin gene promoter fragment driving expression of luciferase were transfected with expression vectors for ATF4 and the various FIAT deletion- or site-specific mutants. Inhibition of ATF4-mediated transcription was compared between wild-type (WT) and LZ FIAT mutants. The deletion mutant FIAT ZIP2 DEL and the sequence-specific M2 mutant did not interact with ATF4 and were unable to inhibit ATF4-mediated transcription. The M1 or M3 mutations did not affect the ability of FIAT to contact ATF4 or to inhibit its transcriptional activity. Stable expression of WT FIAT in osteoblastic cells inhibited mineralization, but not expression of the FIAT ZIP2 DEL and M2 mutants. This structure-function analysis reveals that FIAT interacts with ATF4 and modulates its activity through its second leucine zipper motif. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18680144      PMCID: PMC2574876          DOI: 10.1002/jcb.21881

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  25 in total

Review 1.  Classification of human B-ZIP proteins based on dimerization properties.

Authors:  Charles Vinson; Max Myakishev; Asha Acharya; Alain A Mir; Jonathan R Moll; Maria Bonovich
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

2.  Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity.

Authors:  T Hai; T Curran
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

3.  The role of the leucine zipper in the fos-jun interaction.

Authors:  T Kouzarides; E Ziff
Journal:  Nature       Date:  1988-12-15       Impact factor: 49.962

4.  ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae.

Authors:  Florent Elefteriou; M Douglas Benson; Hideaki Sowa; Michael Starbuck; Xiuyun Liu; David Ron; Luis F Parada; Gerard Karsenty
Journal:  Cell Metab       Date:  2006-12       Impact factor: 27.287

5.  Interaction of the taxilin family with the nascent polypeptide-associated complex that is involved in the transcriptional and translational processes.

Authors:  Kenji Yoshida; Satoru Nogami; Sachie Satoh; Sawako Tanaka-Nakadate; Hideyuki Hiraishi; Akira Terano; Hiromichi Shirataki
Journal:  Genes Cells       Date:  2005-05       Impact factor: 1.891

6.  Amino acid deprivation induces the transcription rate of the human asparagine synthetase gene through a timed program of expression and promoter binding of nutrient-responsive basic region/leucine zipper transcription factors as well as localized histone acetylation.

Authors:  Hong Chen; Yuan-Xiang Pan; Elizabeth E Dudenhausen; Michael S Kilberg
Journal:  J Biol Chem       Date:  2004-09-22       Impact factor: 5.157

7.  ATF4, the osteoblast accumulation of which is determined post-translationally, can induce osteoblast-specific gene expression in non-osteoblastic cells.

Authors:  Xiangli Yang; Gerard Karsenty
Journal:  J Biol Chem       Date:  2004-09-16       Impact factor: 5.157

8.  Identification and characterization of taxilin isoforms.

Authors:  Satoru Nogami; Sachie Satoh; Sawako Tanaka-Nakadate; Kenji Yoshida; Michiko Nakano; Akira Terano; Hiromichi Shirataki
Journal:  Biochem Biophys Res Commun       Date:  2004-07-02       Impact factor: 3.575

9.  The leucine repeat motif in Fos protein mediates complex formation with Jun/AP-1 and is required for transformation.

Authors:  M Schuermann; M Neuberg; J B Hunter; T Jenuwein; R P Ryseck; R Bravo; R Müller
Journal:  Cell       Date:  1989-02-10       Impact factor: 41.582

10.  Leptin regulation of bone resorption by the sympathetic nervous system and CART.

Authors:  Florent Elefteriou; Jong Deok Ahn; Shu Takeda; Michael Starbuck; Xiangli Yang; Xiuyun Liu; Hisataka Kondo; William G Richards; Tony W Bannon; Masaki Noda; Karine Clement; Christian Vaisse; Gerard Karsenty
Journal:  Nature       Date:  2005-02-20       Impact factor: 49.962

View more
  5 in total

1.  Altered gene dosage confirms the genetic interaction between FIAT and αNAC.

Authors:  Bahareh Hekmatnejad; Vice Mandic; Vionnie W C Yu; Omar Akhouayri; Alice Arabian; René St-Arnaud
Journal:  Gene       Date:  2014-01-17       Impact factor: 3.688

Review 2.  Combinatorial control of ATF4-dependent gene transcription in osteoblasts.

Authors:  René St-Arnaud; Bahareh Hekmatnejad
Journal:  Ann N Y Acad Sci       Date:  2011-11       Impact factor: 5.691

3.  FIAT is co-expressed with its dimerization target ATF4 in early osteoblasts, but not in osteocytes.

Authors:  Vionnie W C Yu; Omar Akhouayri; René St-Arnaud
Journal:  Gene Expr Patterns       Date:  2009-02-14       Impact factor: 1.224

4.  Zea mays Taxilin protein negatively regulates opaque-2 transcriptional activity by causing a change in its sub-cellular distribution.

Authors:  Nan Zhang; Zhenyi Qiao; Zheng Liang; Bing Mei; Zhengkai Xu; Rentao Song
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

5.  FIAT Deletion Increases Bone Mass But Does Not Prevent High-Fat-Diet-Induced Metabolic Complications.

Authors:  Bahareh Hekmatnejad; Vionnie W C Yu; William Addison; Vice Mandic; Martin Pellicelli; Alice Arabian; René St-Arnaud
Journal:  Endocrinology       Date:  2017-02-01       Impact factor: 4.736

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.